MOESM1 of Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era

Additional file 1: Table S1. History of IFN-α treatment in human B cell malignancies. Abbreviations: IFN, interferon; ND, newly diagnosed; RR, relapsed and/or refractory; MCL, mantel cell lymphoma; SLL, small lymphocytic lymphoma; FL, follicular lymphoma; DLBCL, diffuse large B cell lymphoma; NHL, non-Hodgkin lymphoma; MALT, mucosa-associated lymphoid tissue; HL, Hodgkin lymphoma; pcMZL, primary cutaneous marginal zone lymphoma; CLL, chronic lymphocytic lymphoma; AITL, angioimmunoblastic T-cell lymphoma; PTCL, peripheral T cell lymphoma; DLCL, diffuse large cell lymphoma; MM, multiple myeloma; WM, Waldenstrom’s macroglobulinemia; NK, natural killer; LG, large granular; IL, interleukin; HDT, high dose treatment; ASCT, autologous stem cell transplant; ABSCT, autologous bone marrow or blood stem cell transplantation; PBSCT, peripheral blood stem cell transplantation; CHOP, cyclophosphamide, vincristine, doxorubicin, and prednisone; UA, unavailable; *IFN Dose: high-dose IFN (5 MIU/m2 daily), low-dose (3 MIU/m2/day, 3 times a week), intermediate-dose, between high and low doses.

附加文件1：表S1。人类B细胞恶性肿瘤的干扰素α（IFN-α）治疗史。缩写说明：IFN（interferon，干扰素）；ND（newly diagnosed，初诊）；RR（relapsed and/or refractory，复发和/或难治性）；MCL（mantel cell lymphoma，套细胞淋巴瘤）；SLL（small lymphocytic lymphoma，小淋巴细胞淋巴瘤）；FL（follicular lymphoma，滤泡性淋巴瘤）；DLBCL（diffuse large B cell lymphoma，弥漫大B细胞淋巴瘤）；NHL（non-Hodgkin lymphoma，非霍奇金淋巴瘤）；MALT（mucosa-associated lymphoid tissue，黏膜相关淋巴组织）；HL（Hodgkin lymphoma，霍奇金淋巴瘤）；pcMZL（primary cutaneous marginal zone lymphoma，原发性皮肤边缘区淋巴瘤）；CLL（chronic lymphocytic lymphoma，慢性淋巴细胞淋巴瘤）；AITL（angioimmunoblastic T-cell lymphoma，血管免疫母细胞性T细胞淋巴瘤）；PTCL（peripheral T cell lymphoma，外周T细胞淋巴瘤）；DLCL（diffuse large cell lymphoma，弥漫大细胞淋巴瘤）；MM（multiple myeloma，多发性骨髓瘤）；WM（Waldenstrom’s macroglobulinemia，华氏巨球蛋白血症）；NK（natural killer，自然杀伤细胞）；LG（large granular，大颗粒淋巴细胞）；IL（interleukin，白细胞介素）；HDT（high dose treatment，大剂量治疗）；ASCT（autologous stem cell transplant，自体干细胞移植）；ABSCT（autologous bone marrow or blood stem cell transplantation，自体骨髓或血液干细胞移植）；PBSCT（peripheral blood stem cell transplantation，外周血干细胞移植）；CHOP（cyclophosphamide, vincristine, doxorubicin, and prednisone，环磷酰胺、长春新碱、阿霉素、泼尼松联合化疗方案）；UA（unavailable，不可获得）；*IFN剂量：高剂量干扰素（每日5 MIU/m²）、低剂量（每周3次，每次3 MIU/m²/天）、中剂量（介于高低剂量之间）。